Skip to content
aiqbench takeMachine Learning

aiqbench analysis

This study reveals a critical gap in open-weight LLMs where they successfully encode clinical risk and cost signals individually but fail to reliably integrate them into balanced decision-making. The findings indicate that larger models show some representational alignment with cost directions, yet most configurations remain insensitive to cost magnitude, suggesting current architectures do not inherently optimize for clinical utility tradeoffs. For developers deploying AI in healthcare, this underscores the necessity of explicit tradeoff testing and phrasing sensitivity checks beyond standard predictive accuracy metrics.
Source coveringarXiv
What this isA model's reading of the article and related coverage, written for aiqbench. Not the publisher's words.

Misaligned Clinical Risk Classification and Cost Asymmetry in Open-Weight Large Language Models

arXiv2 min read

arXiv:2609.23999v1 Announce Type: new Abstract: How large language models (LLMs) integrate patient risk with clinical cost tradeoffs remains poorly understood. We investigated how four open-weight LLMs (Qwen-2.5-7B/32B and Llama-3.1-8B/70B) internally represent cost tradeoffs, how these representations relate to clinical predictions, and whether decisions shift as predicted by the specified cost direction and magnitude. Using a public diabetes dataset, we varied 11 false-negative (FN) to false-positive (FP) cost ratios across three phrasings and examined representations and behavioral outputs. Patient risk was linearly recoverable on par with conventional classifiers (AUC $\approx 0.83$), and cost direction was recoverable in every model. However, representational shifts in cost direction tracked output changes only in the two larger models, and responses to cost magnitude were predominantly direction-agnostic. Only 2 of 12 model-phrasings showed both opposing responses to increasing FN versus FP costs and cost-correct ordering. Representationally, a direction fitted on one cost side did not invert when transferred to the other, as expected under mirror-symmetric encoding. These findings suggest that LLMs encode risk and cost information but do not reliably integrate them into cost-correct decisions. Clinical evaluations should therefore include tradeoff tests, phrasing sensitivity, and default operating points alongside predictive performance.

Abstract:How large language models (LLMs) integrate patient risk with clinical cost tradeoffs remains poorly understood. We investigated how four open-weight LLMs (Qwen-2.5-7B/32B and Llama-3.1-8B/70B) internally represent cost tradeoffs, how these representations relate to clinical predictions, and whether decisions shift as predicted by the specified cost direction and magnitude. Using a public diabetes dataset, we varied 11 false-negative (FN) to false-positive (FP) cost ratios across three phrasings and examined representations and behavioral outputs. Patient risk was linearly recoverable on par with conventional classifiers (AUC $\approx 0.83$), and cost direction was recoverable in every model. However, representational shifts in cost direction tracked output changes only in the two larger models, and responses to cost magnitude were predominantly direction-agnostic. Only 2 of 12 model-phrasings showed both opposing responses to increasing FN versus FP costs and cost-correct ordering. Representationally, a direction fitted on one cost side did not invert when transferred to the other, as expected under mirror-symmetric encoding. These findings suggest that LLMs encode risk and cost information but do not reliably integrate them into cost-correct decisions. Clinical evaluations should therefore include tradeoff tests, phrasing sensitivity, and default operating points alongside predictive performance.

Machine Learning (cs.LG); Artificial Intelligence (cs.AI)

arXiv:2609.23999 [cs.LG]

(or arXiv:2609.23999v1 [cs.LG] for this version)

https://doi.org/10.48550/arXiv.2609.23999 Focus to learn more arXiv-issued DOI via DataCite (pending registration)

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Full text under the publisher's open licence · 287 words

Related coverage